The U.S. Food and Drug Administration issued an emergency use authorization for Pfizer's antiviral pill for the treatment of mild-to-moderate COVID-19 infection on Wednesday.
"Today's authorization introduces the first treatment for COVID-19 that is in the form of a pill that is taken orally - a major step forward in the fight against this global pandemic. This authorization provides a new tool to combat COVID-19 at a crucial time in the pandemic as new variants emerge and promises to make antiviral treatment more accessible to patients who are at high risk for progression to severe COVID-19," said Patrizia Cavazzoni, M.D., director of the FDA's Center for Drug Evaluation and Research.
Pfizer's Paxlovid becomes the first US authorized home COVID-19 treatment.
Paxlovid is not authorized for the pre-exposure or post-exposure prevention of COVID-19 or for initiation of treatment in those requiring hospitalization due to severe or critical COVID-19.
The FDA has approved one vaccine and authorized others to prevent COVID-19 and serious clinical outcomes associated with a COVID-19 infection, including hospitalization and death.
An antiviral pill from Merck & Co. also is expected soon to be authorized for COVID-19 treatment.
Aside from the two pills mentioned above, Ivermectin is believed to be a treatment for COVID-19 based on testimonies from professional doctors, nurses, and COVID-19 patients.
Wednesday, December 22, 2021
FDA Authorizes Pfizer Antiviral Pill for COVID-19 Home Treatment …Sort of Like Ivermectin
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment